Strategic Professor and Head of Clinical Pharmacology
College of Medicine and Public Health
Arduino trained in Clinical Pharmacology, Cardiology and Internal Medicine in Milan, Boston and London. In 2003 he was awarded a PhD at King's College London and was appointed as Senior Lecturer in the Department of Clinical Pharmacology at Flinders University. He was promoted to Associate Professor in 2007 before taking up the Chair of Medicine of Old Age at the University of Aberdeen in 2010. In 2013 he returned to Flinders University as Professor of Clinical Pharmacology and Senior Consultant in Clinical Pharmacology and Internal Medicine.
https://en.wiki.topitalianscientists.org/Arduino_A_Mangoni
MD(Hons), University of Milan, 1991
Specialist Diploma in Cardiology and Internal Medicine, University of Milan (Italy), 1995
Certificate of Completion of Specialist Training in Clinical Pharmacology & Therapeutics, Specialist Training Authority, London (UK), 2003
Certificate of Completion of Specialist Training in General (Internal) Medicine, Specialist Training Authority, London (UK), 2003
PhD, King's College London (UK), 2003
MRCP(UK), 2003
FRACP (General Medicine), 2005
FRCP (London), 2009
FRCP (Glasgow), 2010
FRCP (Edinburgh), 2011
FRACP (Clinical Pharmacology), 2013
Carrick citation for outstanding contributions to student learning "For promotion of safe and effective medication management through an innovative e-learning pharmacology course for Nurse Practitioners in urban, rural and remote areas of Australia". (2007)
Visiting Professor, University of Sassari, Italy (2012, 2014, 2015, 2016, 2018, 2019)
Honorarprofessor, Institut für Pharmakologie und Toxikologie, Technische Universität Dresden, Germany (2019)
Fellow of the British Pharmacological Society (2012)
Fellow of the International Society of Hypertension (2020)
Grants:
2015: AA Mangoni, A Rowland, J Miners, T Chataway, M Michael, MG Burt, D Keating, L Thurgood, M Sorich. Establishment of the Flinders Metabolomic Research facility. Flinders Faculty of Health Sciences, AUD 20,000
2015: MG Burt, AA Mangoni, L Heilbronn. Determination of the effect of relative hyperglycaemia on markers of cardiovascular risk. Flinders Faculty of Health Sciences Small Grants, AUD 19,000
2017: Mangoni AA, Woodman RJ, Shanahan EM, Wiese MD. Effects of methotrexate on blood pressure and arterial function in rheumatoid arthritis. Investigator initiated trial research grant. medac Gesellschaft für klinische Spezialpräparate mbH (Germany), 4 years, AUD 550,000
2019: Pintus GF, Mangoni AA, Zinellu A, Fois A. Investigating predictive biomarkers and cellular/molecular determinants of chronic respiratory diseases. Qatar University Collaborative Grants, 2 years, AUD 359,031
2019: Mangoni AA. Dimethylarginine dimethylaminohydrolase 1: a new target for triple negative breast cancer. Tour de Cure, Senior Research Grants, 1 year, AUD 198,332
2021: Pintus GF, Mangoni AA. Effect of natural antioxidants on diabetes-induced epigenetic modifications in human endothelial cells: an ex-vivo/in-vitro approach. University of Sharjah Collaborative Research Project No. 2101050160, 2 years, AUD 66,629.
Editor-in-Chief: Therapeutic Advances in Drug Safety, Current Clinical Pharmacology, Clinical Medicine Insights: Cardiology
Associate Editor: Age & Ageing
Review Editor: British Journal of Clinical Pharmacology
Executive Member of the National Blood Pressure and Vascular Disease Advisory Committee: review and update of Australian Hypertension Guidelines
SIGN (Scottish Intercollegiate Guidelines Network) Working Group: Management of Chronic Pain
Clinical Pharmacology Consultant for Bellberry Human Research Ethics Committee